AAP
SBC

Arax Advisory Partners’s SBC Medical Group SBC Stock Holding History

Arax Advisory Partners’s Portfolio SBC Stock Details SBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$576 Buy
187
+168
+884% +$570 ﹤0.01% 5005
2026
Q1 		$21 Buy
+19
New +$79 ﹤0.01% 3716
2025
Q4 		– Sell
-409
Closed -$1.77K – 4606
2025
Q3 		$1.77K Buy
+409
New +$1.84K ﹤0.01% 3141

Other funds holding SBC

LK
Lumbard & Kellner Hollis, New Hampshire $330M AUM 65.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $4.39B AUM 72.96% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Arax Advisory Partners's SBC Position: Q2 2026 in Review

Arax Advisory Partners increased its SBC Medical Group (SBC) stake by 884% in Q2 2026, buying an estimated $570 and bringing the position to 187 shares worth $576. The position accounts for ﹤0.01% of the portfolio, ranked #5005.

Arax Advisory Partners first reported a position in SBC in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.77K in Q3 2025. 57 funds tracked by Wall St. Rank hold SBC as of Q2 2026.

  • Arax Advisory Partners held 187 shares of SBC Medical Group worth $576 as of Q2 2026.
  • Arax Advisory Partners bought 168 SBC Medical Group shares in Q2 2026, an estimated $570.
  • SBC Medical Group made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #5005 holding.
  • Arax Advisory Partners first reported a position in SBC Medical Group in Q3 2025 and has held it in 3 quarters since.
  • Arax Advisory Partners's SBC Medical Group position peaked at $1.77K in Q3 2025.
  • 57 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.